The American Journal of Medicine
Volume 123, Issue 5 , Pages 420-422 , May 2010

The Tissue's the Issue

  • Joshua F. Zeidner, MD

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • Corresponding Author InformationRequests for reprints should be addressed to Joshua Zeidner, MD, Department of Medicine, 1830 E Monument St, Rm 9020, Baltimore, MD 21205
    • ,
  • Edwin J. Ostrin, MD, PhD

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • ,
  • Emily Sydnor, MD

      Affiliations

    • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
    • ,
  • Derek Fine, MD

      Affiliations

    • Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD
    • ,
  • C. John Sperati, MD, MHS

      Affiliations

    • Division of Nephrology, Johns Hopkins University School of Medicine, Baltimore, MD

References 

  1. Bolton WK. Goodpasture's syndrome. Kidney Int. 1996;50:1753–1766
  2. Hirayama K, Yamagata K, Kobayashi M, Koyama A. Anti-glomerular basement membrane antibody disease in Japan: part of the nationwide rapidly progressive glomerulonephritis survey in Japan. Clin Exp Nephrol. 2008;12:339–347
  3. Goodpasture EW. The significance of certain pulmonary lesions in relation to the etiology of influenza. Am J Med Sci. 1919;158:863–870
  4. Stanton MC, Tange JD. Goodpasture's syndrome (pulmonary hemorrhage associated with glomerulonephritis). Australas Ann Med. 1958;7:132–144
  5. Lionaki S, Jennette JC, Falk RJ. Anti-neutrophil cytoplasmic (ANCA) and anti-glomerular basement membrane (GBM) autoantibodies in necrotizing and crescentic glomerulonephritis. Semin Immunopathol. 2007;29:459–474
  6. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348:2543–2556
  7. Levy JB, Hammad T, Coulthart A, et al. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535–1540
  8. Levy JB, Turner AN, Rees AJ, Pusey CD. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033–1042
  9. Kaplan AA. The use of apheresis in immune renal disorders. Ther Apher Dial. 2003;7:165–172
  10. Cameron JS. Glomerulonephritis in renal transplants. Transplantation. 1982;34:237–245
  11. Netzer KO, Merkel F, Weber M. Goodpasture syndrome and end-stage renal failure—to transplant or not to transplant?. Nephrol Dial Transplant. 1998;13:1346–1348

 Aimee K. Zaas, MD, Section Editor

 Funding: None.

 Conflict of Interest: None.

 Authorship: Authors had access to the data and had a role in writing the manuscript. Each author has seen and approved the final version of the manuscript.

PII: S0002-9343(10)00074-4

doi: 10.1016/j.amjmed.2010.01.008

The American Journal of Medicine
Volume 123, Issue 5 , Pages 420-422 , May 2010

Article Tools

* Image Usage & Resolution